About Us


NKMAX Canada Inc. is an immunodiagnostic company focused on the development of in vitro diagnostic devices for the analysis of patients’ immune function. Immunosurveillance performed by lymphoid cells is important in immunity against foreign antigens and tumor cells.

NKMAX Canada Inc. is subsidiary of NKMAX Co Ltd., a company founded in 2002 in South Korea. NKMAX Co Ltd. Is a biotech company that manufactures and supplies a wide array of recombinant proteins and antibodies worldwide. NKMAX’s proprietary stable protein technology has enabled the company to expand into the development of in vitro diagnostic devices, several of which are under development for immune system monitoring.